Atrogi’s breakthrough discovery enables chronic use of next-generation, highly selective β2-agonists for the first time in metabolic diseaseFirst-in-class oral therapy ATR-258 mimics the effects of ...

Indian astronaut Shubhanshu Shukla -- who is en route to the International Space Station (ISS) to become the first from Ind ...

If the drug is more broadly used in people with obesity and not just diabetes, those with higher body weights may see even ...

Kevin Murach, an assistant professor at the University of Arkansas, Fayetteville who previously received a multimillion-dollar National Institutes of Health grant to study the impact of exercise on ...

Expert witnesses in toxicology and forensic pathology testified in the second day of the murder trial for Marcy Oglesby.

Researchers found that lower lean muscle mass and higher intermuscular adipose tissue acted as imaging-visible markers that ...

CREATINE IS MORE popular than ever, and many guys credit the supplement for helping them build stronger muscles, boost their ...

Capricor's DMD therapy Deramiocel is under FDA Priority Review with no major issues flagged; PDUFA date set for August 31, 2025.

The results indicated that subjects who switched from alglucosidase alfa to cipa+mig generally achieved improvements or ...

Exercise is an important part of any weight loss program, but knowing which exercises to include can be a challenge.

A new potential drug treatment for people with type 2 diabetes and obesity lowers blood sugar and increases fat burning.